Literature DB >> 26535964

Stress-induced anhedonia is associated with the activation of the inflammatory system in the rat brain: Restorative effect of pharmacological intervention.

Andrea C Rossetti1, Mariusz Papp2, Piotr Gruca3, Maria Serena Paladini4, Giorgio Racagni5, Marco A Riva6, Raffaella Molteni7.   

Abstract

Major depression is a complex disease that originates from the interaction between a genetic background of susceptibility and environmental factors such as stress. At molecular level, it is characterized by dysfunctions of multiple systems including neurotransmitters, hormones, signalling pathways, neurotrophic and neuroplastic molecules and - more recently - inflammatory mediators. Accordingly, in the present study we used the chronic mild stress (CMS) paradigm in the rat to elucidate to what extent brain inflammation may contribute to the development and/or the maintenance of an anhedonic phenotype and how pharmacological intervention may interfere with such behavioral and molecular stress-induced alterations. To this aim, adult male rats were exposed to CMS for 2 weeks and the cerebral expression of several mediators of the inflammatory system was evaluated in the hippocampus and prefrontal cortex of both stressed and control animals in parallel with the sucrose intake. Next, the animals that showed a decreased sucrose consumption were exposed to five further weeks of CMS and treated with the antidepressants imipramine or agomelatine, or the antipsychotic lurasidone. Our results demonstrate that only the stressed animals that were characterized by a deficit in sucrose intake showed increased expression of the pro-inflammatory cytokines IL-1β, IL-6 and up-regulation of markers and mediators of microglia activation such as CD11b, CX3CL1 and its receptor CX3CR1 in comparison with stress-resilient animals. Some of these molecular alterations persisted also after longer stress exposure and were modulated, similarly to the behavioral effects of CMS, by chronic pharmacological treatment. These data suggest that neuroinflammation may have a key role in the pathological consequences of stress exposure, thus contributing to the subject's vulnerability for depression.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Agomelatine: N-[2-(7-methoxynaphthalen-1-yl) ethyl]acetamide; Antidepressant; Chronic mild stress; Cytokines; Differential susceptibility; Imipramine: 3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine; Lurasidone: (3aR,4S,7R,7aS)-2-{(1R,2R)-2-[4-(1,2-benzisothiazol-3-yl) piperazin-1-ylmethyl] cyclohexylmethyl} hexahydro-4,7-methano-2H-isoindole-1,3-dione; Microglia activation; Sucrose intake

Mesh:

Substances:

Year:  2015        PMID: 26535964     DOI: 10.1016/j.phrs.2015.10.022

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  20 in total

1.  Unpredictable Chronic Mild Stress Paradigm Established Effects of Pro- and Anti-inflammatory Cytokine on Neurodegeneration-Linked Depressive States in Hamsters with Brain Endothelial Damages.

Authors:  Ennio Avolio; Gilda Fazzari; Maria Mele; Raffaella Alò; Merylin Zizza; Wei Jiao; Anna Di Vito; Tullio Barni; Maurizio Mandalà; Marcello Canonaco
Journal:  Mol Neurobiol       Date:  2016-10-11       Impact factor: 5.590

2.  Investigating dopamine and glucocorticoid systems as underlying mechanisms of anhedonia.

Authors:  Steven J Lamontagne; Sofia I Melendez; Mary C Olmstead
Journal:  Psychopharmacology (Berl)       Date:  2018-08-22       Impact factor: 4.530

Review 3.  Environmental Contributions to Anhedonia.

Authors:  Kate L Harkness; Steven J Lamontagne; Simone Cunningham
Journal:  Curr Top Behav Neurosci       Date:  2022

Review 4.  Adolescent neuroimmune function and its interaction with alcohol.

Authors:  T L Doremus-Fitzwater; T Deak
Journal:  Int Rev Neurobiol       Date:  2021-10-04       Impact factor: 4.280

5.  Differential effects of acute versus chronic stress on ethanol sensitivity: Evidence for interactions on both behavioral and neuroimmune outcomes.

Authors:  Tamara L Doremus-Fitzwater; Jacqueline E Paniccia; Anny Gano; Andrew S Vore; Terrence Deak
Journal:  Brain Behav Immun       Date:  2018-02-17       Impact factor: 7.217

Review 6.  The chronic mild stress (CMS) model of depression: History, evaluation and usage.

Authors:  Paul Willner
Journal:  Neurobiol Stress       Date:  2016-08-24

7.  Gunn rats with glial activation in the hippocampus show prolonged immobility time in the forced swimming test and tail suspension test.

Authors:  Ryosuke Arauchi; Sadayuki Hashioka; Keiko Tsuchie; Tsuyoshi Miyaoka; Toshiko Tsumori; Erlyn Limoa; Ilhamuddin A Azis; Arata Oh-Nishi; Shoko Miura; Koji Otsuki; Misako Kanayama; Muneto Izuhara; Michiharu Nagahama; Kiminori Kawano; Tomoko Araki; Kristian Liaury; Rostia A Abdullah; Rei Wake; Maiko Hayashida; Ken Inoue; Jun Horiguchi
Journal:  Brain Behav       Date:  2018-06-28       Impact factor: 2.708

8.  Chronic Stress Exposure Reduces Parvalbumin Expression in the Rat Hippocampus through an Imbalance of Redox Mechanisms: Restorative Effect of the Antipsychotic Lurasidone.

Authors:  Andrea C Rossetti; Maria Serena Paladini; Martina Colombo; Piotr Gruca; Magdalena Lason-Tyburkiewicz; Katarzyna Tota-Glowczyk; Mariusz Papp; Marco A Riva; Raffaella Molteni
Journal:  Int J Neuropsychopharmacol       Date:  2018-09-01       Impact factor: 5.176

9.  The Modulatory Properties of Chronic Antidepressant Drugs Treatment on the Brain Chemokine - Chemokine Receptor Network: A Molecular Study in an Animal Model of Depression.

Authors:  Ewa Trojan; Joanna Ślusarczyk; Katarzyna Chamera; Katarzyna Kotarska; Katarzyna Głombik; Marta Kubera; Agnieszka Basta-Kaim
Journal:  Front Pharmacol       Date:  2017-11-01       Impact factor: 5.810

10.  BACHD rats expressing full-length mutant huntingtin exhibit differences in social behavior compared to wild-type littermates.

Authors:  Giuseppe Manfré; Arianna Novati; Ilaria Faccini; Andrea C Rossetti; Kari Bosch; Raffaella Molteni; Marco A Riva; Johanneke E Van der Harst; Huu Phuc Nguyen; Judith R Homberg
Journal:  PLoS One       Date:  2018-02-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.